Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Total article views   HTML views PDF downloads Totals
16,910 Dovepress* 13,860+ 3,625 17,485
PubMed Central* 3,050 1,768 4,818
Totals 16,910 5,393 22,303
*Since 31 July 2012
+Since July 2016

View citations on PubMed Central and Google Scholar